Health Care · Biological Products, (No Diagnostic Substances) · NYSE · CIK 725363 · FYE Sep 30 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $1.14Day −5.00%Mkt cap $10M1Y −84.1%Off 52W high −91.5%Vol (1Y) 117.1%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,523 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest8.5% of sh out |
| Days to cover1.8d |
| 13F net flow (QoQ)+0.41% |
| Top-10 13F concentration87.7% |
| Next report (est.)2026-08-14 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$22.7M |
| ROE−176.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−78.3% |
| 1Y−84.1% |
| 3Y−97.6% |
| 5Y−99.5% |
| 10Y−99.7% |
| Since incept. (ann.)−43.5% |
Total return through 2026-07-29 · series begins 2016-07-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)117.1% |
| Ann. volatility (3Y)118.0% |
| Sharpe (1Y)−1.15 |
| Sharpe (3Y)−0.49 |
| Max drawdown (1Y)−92.5% |
| Max drawdown (3Y)−99.0% |
| Beta (3Y vs SPY)0.92 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 243,645 | $782,100 | 2.87% | new |
| MAI Capital Management | 91,280 | $293,009 | 1.07% | +1.7% |
| GEODE CAPITAL MANAGEMENT, LLC | 85,311 | $273,988 | 1.00% | +7.7% |
| VANGUARD FIDUCIARY TRUST CO | 49,036 | $157,406 | 0.58% | new |
| BlackRock, Inc. | 43,261 | $138,868 | 0.51% | +0.0% |
| BANK OF AMERICA CORP /DE/ | 40,997 | $131,600 | 0.48% | +0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 35,890 | $115,207 | 0.42% | +133.0% |
| US BANCORP \DE\ | 29,907 | $96,001 | 0.35% | +62.4% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | −$0.67 | — | — | — |
| 2025-12-31 | 2026-02-17 | −$0.68 | — | — | — |
| 2025-06-30 | 2025-08-14 | −$1.36 | — | — | — |
| 2025-03-31 | 2025-05-14 | — | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-14 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
